ArticleBMC cancer2024

Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy.

Shaoyan Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.